In recent years, five other drugs have been approved to treat gMG, including three complement inhibitors -- eculizumab (Soliris), ravulizumab (Ultomiris), and zilucoplan (Zilbrysq) – and two neonatal ...

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new ...

Generalized myasthenia gravis is Uplizna’s second new indication this year, after the FDA cleared the anti-CD19 antibody for ...

The axolotl, a type of salamander that stays in the tadpole form throughout its life, is a master of regeneration. Axolotls ...

It began as something deceptively simple when I was 52. After long flights and longer workdays as a global marketing ...

Regeneron’s cemdisiran, used alone or in combination with its complement inhibitor Veopoz, significantly improved activities of daily living in patients with generalized myasthenia gravis. Regeneron’s ...

A NEWLY developed nurse-led nomogram has shown strong potential in predicting the risk of myasthenic crisis in patients with myasthenia gravis and bulbar weakness. The model, based on logistic ...

In a retrospective analysis, investigators in Finland studied the risk factors for intensive care unit (ICU) admission among patients with MG. Patients with MG who needed intensive care tended to be ...

Myasthenia gravis, or MG, is "a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue," says Hesterlee. It occurs "when a person’s immune system is essentially attacking ...

In 2011, at age 25, Youssef Heddaya was diagnosed with thymoma, a typically slow-growing tumor that develops in the thymus, a small organ in the chest that is vital to the immune system. Located near ...